Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ThromboSol-preserved Autologous Platelets vs Fresh Random Platelets
NCT00074763Phase 3Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jul 2003
- Primary completion
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ThromboSol in Thrombocytopenia, sponsored by University of Texas MD Anderson Cancer Center. Started Jul 2003; status: terminated.
02
Drugs
ThromboSol
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT00074763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00074763.